Can complementary and alternative medicine clinical cancer research be successfully accomplished? The Mayo Clinic-North Central Cancer Treatment Group experience.
Identifieur interne : 002430 ( Ncbi/Merge ); précédent : 002429; suivant : 002431Can complementary and alternative medicine clinical cancer research be successfully accomplished? The Mayo Clinic-North Central Cancer Treatment Group experience.
Auteurs : Debra L. Barton [États-Unis] ; Charles Loprinzi ; Aminah Jatoi ; Ann Vincent ; Paul Limburg ; Brent Bauer ; Amit Sood ; Marge Good ; James D. Bearden ; Joseph Kelaghan ; Jeff SloanSource :
- Journal of the Society for Integrative Oncology [ 1715-894X ] ; 2006.
Descripteurs français
- KwdFr :
- MESH :
- Wicri :
- geographic : États-Unis.
English descriptors
- KwdEn :
- MESH :
- geographic : United States.
- therapy : Neoplasms.
- Biomedical Research, Cancer Care Facilities, Clinical Trials as Topic, Complementary Therapies, Humans, Prognosis.
Abstract
Some critics question whether research on complementary and alternative modalities for patients with cancer can be done efficiently in traditional clinical settings. This article reviews a program of complementary medicine research that has been done in a traditional clinical setting over the past 30 years. Trials using complementary therapies for both symptom management and cancer treatment done by the Mayo Clinic and the North Central Cancer Treatment Group are reviewed. Twenty-seven studies have been developed using complementary therapies, addressing such issues as mucosal and epidermal toxicity, hot flashes, lymphedema, anorexia and cachexia, insomnia, cognitive dysfunction, fatigue, and cancer treatment. Nineteen of them have been completed and have had results published in peer-reviewed clinical journals, whereas two manuscripts are in press. Two other trials have recently completed accrual, and the data are being analyzed so that manuscripts can be prepared. In addition, four clinical trials are actively accruing patients. The data presented in this article demonstrate that complementary and alternative medicine research can be done in a scientifically sound manner. Well-designed and adequately powered studies can be implemented, and large numbers of patients can be accrued. The resulting research evaluations can be published in peer-reviewed medical journals.
PubMed: 17022922
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003865
- to stream PubMed, to step Curation: 003865
- to stream PubMed, to step Checkpoint: 003865
Links to Exploration step
pubmed:17022922Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Can complementary and alternative medicine clinical cancer research be successfully accomplished? The Mayo Clinic-North Central Cancer Treatment Group experience.</title><author><name sortKey="Barton, Debra L" sort="Barton, Debra L" uniqKey="Barton D" first="Debra L" last="Barton">Debra L. Barton</name><affiliation wicri:level="2"><nlm:affiliation>Mayo Clinic College of Medicine, Rochester, MN 55905, USA. barton.debra@mayo.edu</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Mayo Clinic College of Medicine, Rochester, MN 55905</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author><author><name sortKey="Loprinzi, Charles" sort="Loprinzi, Charles" uniqKey="Loprinzi C" first="Charles" last="Loprinzi">Charles Loprinzi</name></author><author><name sortKey="Jatoi, Aminah" sort="Jatoi, Aminah" uniqKey="Jatoi A" first="Aminah" last="Jatoi">Aminah Jatoi</name></author><author><name sortKey="Vincent, Ann" sort="Vincent, Ann" uniqKey="Vincent A" first="Ann" last="Vincent">Ann Vincent</name></author><author><name sortKey="Limburg, Paul" sort="Limburg, Paul" uniqKey="Limburg P" first="Paul" last="Limburg">Paul Limburg</name></author><author><name sortKey="Bauer, Brent" sort="Bauer, Brent" uniqKey="Bauer B" first="Brent" last="Bauer">Brent Bauer</name></author><author><name sortKey="Sood, Amit" sort="Sood, Amit" uniqKey="Sood A" first="Amit" last="Sood">Amit Sood</name></author><author><name sortKey="Good, Marge" sort="Good, Marge" uniqKey="Good M" first="Marge" last="Good">Marge Good</name></author><author><name sortKey="Bearden, James D" sort="Bearden, James D" uniqKey="Bearden J" first="James D" last="Bearden">James D. Bearden</name></author><author><name sortKey="Kelaghan, Joseph" sort="Kelaghan, Joseph" uniqKey="Kelaghan J" first="Joseph" last="Kelaghan">Joseph Kelaghan</name></author><author><name sortKey="Sloan, Jeff" sort="Sloan, Jeff" uniqKey="Sloan J" first="Jeff" last="Sloan">Jeff Sloan</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2006">2006</date><idno type="RBID">pubmed:17022922</idno><idno type="pmid">17022922</idno><idno type="wicri:Area/PubMed/Corpus">003865</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003865</idno><idno type="wicri:Area/PubMed/Curation">003865</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003865</idno><idno type="wicri:Area/PubMed/Checkpoint">003865</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003865</idno><idno type="wicri:Area/Ncbi/Merge">002430</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Can complementary and alternative medicine clinical cancer research be successfully accomplished? The Mayo Clinic-North Central Cancer Treatment Group experience.</title><author><name sortKey="Barton, Debra L" sort="Barton, Debra L" uniqKey="Barton D" first="Debra L" last="Barton">Debra L. Barton</name><affiliation wicri:level="2"><nlm:affiliation>Mayo Clinic College of Medicine, Rochester, MN 55905, USA. barton.debra@mayo.edu</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Mayo Clinic College of Medicine, Rochester, MN 55905</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author><author><name sortKey="Loprinzi, Charles" sort="Loprinzi, Charles" uniqKey="Loprinzi C" first="Charles" last="Loprinzi">Charles Loprinzi</name></author><author><name sortKey="Jatoi, Aminah" sort="Jatoi, Aminah" uniqKey="Jatoi A" first="Aminah" last="Jatoi">Aminah Jatoi</name></author><author><name sortKey="Vincent, Ann" sort="Vincent, Ann" uniqKey="Vincent A" first="Ann" last="Vincent">Ann Vincent</name></author><author><name sortKey="Limburg, Paul" sort="Limburg, Paul" uniqKey="Limburg P" first="Paul" last="Limburg">Paul Limburg</name></author><author><name sortKey="Bauer, Brent" sort="Bauer, Brent" uniqKey="Bauer B" first="Brent" last="Bauer">Brent Bauer</name></author><author><name sortKey="Sood, Amit" sort="Sood, Amit" uniqKey="Sood A" first="Amit" last="Sood">Amit Sood</name></author><author><name sortKey="Good, Marge" sort="Good, Marge" uniqKey="Good M" first="Marge" last="Good">Marge Good</name></author><author><name sortKey="Bearden, James D" sort="Bearden, James D" uniqKey="Bearden J" first="James D" last="Bearden">James D. Bearden</name></author><author><name sortKey="Kelaghan, Joseph" sort="Kelaghan, Joseph" uniqKey="Kelaghan J" first="Joseph" last="Kelaghan">Joseph Kelaghan</name></author><author><name sortKey="Sloan, Jeff" sort="Sloan, Jeff" uniqKey="Sloan J" first="Jeff" last="Sloan">Jeff Sloan</name></author></analytic><series><title level="j">Journal of the Society for Integrative Oncology</title><idno type="ISSN">1715-894X</idno><imprint><date when="2006" type="published">2006</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Biomedical Research</term><term>Cancer Care Facilities</term><term>Clinical Trials as Topic</term><term>Complementary Therapies</term><term>Humans</term><term>Neoplasms (therapy)</term><term>Prognosis</term><term>United States</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Essais cliniques comme sujet</term><term>Humains</term><term>Pronostic</term><term>Recherche biomédicale</term><term>Thérapies complémentaires</term><term>Tumeurs ()</term><term>Établissements de cancérologie</term><term>États-Unis d'Amérique</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>United States</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Biomedical Research</term><term>Cancer Care Facilities</term><term>Clinical Trials as Topic</term><term>Complementary Therapies</term><term>Humans</term><term>Prognosis</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Essais cliniques comme sujet</term><term>Humains</term><term>Pronostic</term><term>Recherche biomédicale</term><term>Thérapies complémentaires</term><term>Tumeurs</term><term>Établissements de cancérologie</term><term>États-Unis d'Amérique</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>États-Unis</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Some critics question whether research on complementary and alternative modalities for patients with cancer can be done efficiently in traditional clinical settings. This article reviews a program of complementary medicine research that has been done in a traditional clinical setting over the past 30 years. Trials using complementary therapies for both symptom management and cancer treatment done by the Mayo Clinic and the North Central Cancer Treatment Group are reviewed. Twenty-seven studies have been developed using complementary therapies, addressing such issues as mucosal and epidermal toxicity, hot flashes, lymphedema, anorexia and cachexia, insomnia, cognitive dysfunction, fatigue, and cancer treatment. Nineteen of them have been completed and have had results published in peer-reviewed clinical journals, whereas two manuscripts are in press. Two other trials have recently completed accrual, and the data are being analyzed so that manuscripts can be prepared. In addition, four clinical trials are actively accruing patients. The data presented in this article demonstrate that complementary and alternative medicine research can be done in a scientifically sound manner. Well-designed and adequately powered studies can be implemented, and large numbers of patients can be accrued. The resulting research evaluations can be published in peer-reviewed medical journals.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17022922</PMID><DateCreated><Year>2006</Year><Month>10</Month><Day>06</Day></DateCreated><DateCompleted><Year>2007</Year><Month>01</Month><Day>18</Day></DateCompleted><DateRevised><Year>2007</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1715-894X</ISSN><JournalIssue CitedMedium="Print"><Volume>4</Volume><Issue>4</Issue><PubDate><Year>2006</Year><Season>Fall</Season></PubDate></JournalIssue><Title>Journal of the Society for Integrative Oncology</Title><ISOAbbreviation>J Soc Integr Oncol</ISOAbbreviation></Journal><ArticleTitle>Can complementary and alternative medicine clinical cancer research be successfully accomplished? The Mayo Clinic-North Central Cancer Treatment Group experience.</ArticleTitle><Pagination><MedlinePgn>143-52</MedlinePgn></Pagination><Abstract><AbstractText>Some critics question whether research on complementary and alternative modalities for patients with cancer can be done efficiently in traditional clinical settings. This article reviews a program of complementary medicine research that has been done in a traditional clinical setting over the past 30 years. Trials using complementary therapies for both symptom management and cancer treatment done by the Mayo Clinic and the North Central Cancer Treatment Group are reviewed. Twenty-seven studies have been developed using complementary therapies, addressing such issues as mucosal and epidermal toxicity, hot flashes, lymphedema, anorexia and cachexia, insomnia, cognitive dysfunction, fatigue, and cancer treatment. Nineteen of them have been completed and have had results published in peer-reviewed clinical journals, whereas two manuscripts are in press. Two other trials have recently completed accrual, and the data are being analyzed so that manuscripts can be prepared. In addition, four clinical trials are actively accruing patients. The data presented in this article demonstrate that complementary and alternative medicine research can be done in a scientifically sound manner. Well-designed and adequately powered studies can be implemented, and large numbers of patients can be accrued. The resulting research evaluations can be published in peer-reviewed medical journals.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barton</LastName><ForeName>Debra L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Mayo Clinic College of Medicine, Rochester, MN 55905, USA. barton.debra@mayo.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loprinzi</LastName><ForeName>Charles</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Jatoi</LastName><ForeName>Aminah</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Vincent</LastName><ForeName>Ann</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Limburg</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Bauer</LastName><ForeName>Brent</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Sood</LastName><ForeName>Amit</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Good</LastName><ForeName>Marge</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Bearden</LastName><ForeName>James D</ForeName><Initials>JD</Initials><Suffix>4th</Suffix></Author><Author ValidYN="Y"><LastName>Kelaghan</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Sloan</LastName><ForeName>Jeff</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CA-25224</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA-35101</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA-35103</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA-35195</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA-35269</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA-35272</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA-35448</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA-37404</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA-37417</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA-52352</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA-60276</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA-63848</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA-63849</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>J Soc Integr Oncol</MedlineTA><NlmUniqueID>101262057</NlmUniqueID><ISSNLinking>1715-894X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="Y">Biomedical Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002173" MajorTopicYN="N">Cancer Care Facilities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000529" MajorTopicYN="Y">Complementary Therapies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>35</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>10</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>1</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>10</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17022922</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Minnesota</li></region></list><tree><noCountry><name sortKey="Bauer, Brent" sort="Bauer, Brent" uniqKey="Bauer B" first="Brent" last="Bauer">Brent Bauer</name><name sortKey="Bearden, James D" sort="Bearden, James D" uniqKey="Bearden J" first="James D" last="Bearden">James D. Bearden</name><name sortKey="Good, Marge" sort="Good, Marge" uniqKey="Good M" first="Marge" last="Good">Marge Good</name><name sortKey="Jatoi, Aminah" sort="Jatoi, Aminah" uniqKey="Jatoi A" first="Aminah" last="Jatoi">Aminah Jatoi</name><name sortKey="Kelaghan, Joseph" sort="Kelaghan, Joseph" uniqKey="Kelaghan J" first="Joseph" last="Kelaghan">Joseph Kelaghan</name><name sortKey="Limburg, Paul" sort="Limburg, Paul" uniqKey="Limburg P" first="Paul" last="Limburg">Paul Limburg</name><name sortKey="Loprinzi, Charles" sort="Loprinzi, Charles" uniqKey="Loprinzi C" first="Charles" last="Loprinzi">Charles Loprinzi</name><name sortKey="Sloan, Jeff" sort="Sloan, Jeff" uniqKey="Sloan J" first="Jeff" last="Sloan">Jeff Sloan</name><name sortKey="Sood, Amit" sort="Sood, Amit" uniqKey="Sood A" first="Amit" last="Sood">Amit Sood</name><name sortKey="Vincent, Ann" sort="Vincent, Ann" uniqKey="Vincent A" first="Ann" last="Vincent">Ann Vincent</name></noCountry><country name="États-Unis"><region name="Minnesota"><name sortKey="Barton, Debra L" sort="Barton, Debra L" uniqKey="Barton D" first="Debra L" last="Barton">Debra L. Barton</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002430 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 002430 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:17022922
|texte= Can complementary and alternative medicine clinical cancer research be successfully accomplished? The Mayo Clinic-North Central Cancer Treatment Group experience.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:17022922" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |